Clinical Trials
50 trials registered for Phenylketonuria
Phenylketonuria and Hyperphenylalaninemia Nutrition Study
NCT01879995N/AUniversity of Zurich
Completed↗
Protein Requirements in Adults With Phenylketonuria (PKU)
NCT03939052N/AUniversity of British Columbia
Completed↗
Protein Requirements in Children With Phenylketonuria (PKU)
NCT01965691N/AUniversity of British Columbia
Completed↗
Remote Neurocognitive and Psychological Assessment in PKU
NCT04943393N/AUniversity of Missouri-Columbia
Completed↗
Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
NCT01082328Phase 4Merck KGaA, Darmstadt, Germany
Completed↗
Study of a National Cohort of Adult Patients With Phenylketonuria
NCT01619722N/AUniversity Hospital, Tours
Completed↗
Study of Low-grade Systemic Inflammation in Adult Patients With Phenylketonuria
NCT04879277N/AUniversity Hospital, Tours
Completed↗
The Brain and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
NCT02297347N/ABoston Children's Hospital
Completed↗
The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
NCT00892554N/AEmory University
Completed↗
The Struggle That Is Phenylketonuria : What Do The Patients and Caregivers Suffer From
NCT06280261N/AHacettepe University
Completed↗
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
NCT07241234Phase 1Agios Pharmaceuticals, Inc.
Not Yet Recruiting↗
Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.
NCT06289348N/AAssistance Publique - Hôpitaux de Paris
Not Yet Recruiting↗
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
NCT07477691Phase 4BioMarin Pharmaceutical
Not Yet Recruiting↗
The Psychosocial Functioning of Adults With Phenylketonuria.
NCT07406009N/ACentral Hospital, Nancy, France
Not Yet Recruiting↗
To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria
NCT07318909Early Phase 1Gritgen Therapeutics Co., Ltd.
Not Yet Recruiting↗
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
NCT05813678N/ABioMarin Pharmaceutical
Recruiting↗
A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria
NCT06637514Phase 2Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting↗
Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria
NCT06337864N/ARigshospitalet, Denmark
Recruiting↗
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
NCT04404530N/AEmory University
Recruiting↗
Safety and Efficacy Study of NGGT002 in PKU Adult Subjects
NCT06061614Early Phase 1The First Affiliated Hospital of Bengbu Medical University
Recruiting↗